SCHEMBL5885604

SCHEMBL5885604

COc1ccc(COc2ccc(C=O)c(OC)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.68
NPC1 O15118 4/20 0.61
RAB9A P51151 4/20 0.61
TDP1 Q9NUW8 1/20 0.61
TUBB1 Q9H4B7 1/20 0.58
APP P05067 3/20 0.53
HDAC8 Q9BY41 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
TRIM24 O15164 1/20 0.49
TYR P14679 1/20 0.49
TRIM33 Q9UPN9 1/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP1B1 Q16678 1/20 0.49
MAOB P27338 3/20 0.48
ERN1 O75460 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21370452 0.94 NPC1 (0.61) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL14367331 0.91 ALDH1A1 (0.60) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL31591495 0.90 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL31533148 0.90 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL435043 0.90 ALDH1A1 (0.61) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL28611584 0.88 TUBB1 (0.74) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL15474693 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL22090594 0.86 HDAC8 (0.53) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL6690276 0.86 ALDH1A1 (0.65) ALDH1A1NPC1RAB9ATDP1TUBB1
SCHEMBL7147744 0.85 TUBB1 (0.66) ALDH1A1NPC1RAB9ATDP1TUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323816-A1 NOVEL PYRAZOLE DERIVATIVE Green Tech Co., Ltd. (JP) 2018-05-23 EP disclosed
US-9399635-B2 Pyrazole derivative GREEN TECH CO., LTD. (JP) 2016-07-26 US disclosed
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PHARMA EIGHT CO., LTD. (JP) 2014-03-27 US disclosed
EP-2698368-A1 NOVEL PYRAZOLE DERIVATIVE Pharma Eight Co. Ltd (JP) 2014-02-19 EP disclosed
US-7119095-B2 Pharmaceutically active compounds and methods of use thereof DANA FARBER CANCER INSTITUTE (US) 2006-10-10 US disclosed
US-20040242614-A1 Pharmaceutically active compounds and methods of use thereof DANA-FARBER CANCER INSTITUTE 2004-12-02 US disclosed
WO-2003043979-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF DANA FARBER CANCER INSTITUTE (US) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PSEN2, MAPT, PSEN1 ALDH1A1 675/4885NPC1 444/4885RAB9A 1154/4885
US-20040242614-A1 Pharmaceutically active compounds and methods of use thereof DHFR, DPYD, MTHFD1 ALDH1A1 218/4885NPC1 665/4885RAB9A 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.